PV Bulletin

GE HealthCare Carestation Devices - Correction for Ineffective Ventilation in VCV Mode (FDA Class I Recall)

FDA issued a Class I recall for GE HealthCare Carestation 620/650/650c and 750/750c Anesthesia Systems due to risk of ineffective ventilation in VCV mode.

PV Impact Brief

Urgency: HighConfidence: high

What changed

FDA published a Class I recall for GE HealthCare Carestation Anesthesia Systems on June 5, 2026, based on a device correction initiated March 21, 2025.

Why it matters

The defect can cause failure of ventilation leading to hypoxia and death if VCV mode is used without correction.

Action needed

Do not use VCV mode until corrected. Use PCV or PCV-VG mode. Perform Ventilation Screening Test. Return acknowledgement form to GE HealthCare.

Relevant for
Regulatory Intelligence LeadSignal Management Lead
Processes impacted
Signal ManagementLabeling
Owner

Regulatory Intelligence Lead

Review cadence

Immediate review required; monitor for updates from GE HealthCare and FDA.

Regulatory action details

Action type
Medical Device Recall / Correction
Publication date
2026-06-05
Safety issue
GE HealthCare is correcting certain Carestation devices due to the risk that they may not provide effective ventilation when used in Volume Control Ventilation (VCV) mode. This can lead to serious injury or death.

Affected products

  • Carestation 620/650/650c and 750/750c Anesthesia Systems
    GE HealthCare

PV internal implications

Do not use VCV mode until corrected. Use PCV or PCV-VG mode. Perform Ventilation Screening Test. Return acknowledgement form.

View regulator source

Evidence and confidence

Confidence: highSource updated: Jun 5, 2026

Full briefing

Practical implication

Do not use VCV mode until corrected. Use PCV or PCV-VG mode. Perform Ventilation Screening Test. Return acknowledgement form to GE HealthCare.

GE HealthCare is correcting certain Carestation devices (620, 650, 650c, 750, 750c) due to risk of ineffective ventilation when used in Volume Control Ventilation (VCV) mode. The FDA has identified this as a Class I recall. Users are instructed not to use VCV mode until correction; instead use PCV or PCV-VG mode, perform Ventilation Screening Test, and return acknowledgement form. No serious injuries or deaths reported yet.

What changed: FDA published a Class I recall for GE HealthCare Carestation Anesthesia Systems on June 5, 2026, based on a device correction initiated March 21, 2025.

Why it matters: The defect can cause failure of ventilation leading to hypoxia and death if VCV mode is used without correction.

Practical implication: Do not use VCV mode until corrected. Use PCV or PCV-VG mode. Perform Ventilation Screening Test. Return acknowledgement form to GE HealthCare.

View original source

Published from the Firecrawl agent regulatory extraction pipeline.

Related updates for your role

publicFDA · USA · Updated Sep 4, 2026

FDA Grants Accelerated Approval to Etcamah for Advanced Breast Cancer

Urgency: High

Regulatory teams must prepare for updating labeling to include details on the new indication and required diagnostic methods, along with planning for the confirmatory studies mandated by the FDA.

Signal ManagementLabelingRegulatory Intelligence Lead
SOP Impact2 SOPs
ConfidenceHigh
Relevant for: Regulatory Intelligence Lead
verifiedRegulatory action: Regulators
Read impact briefarrow_forward
publicMHRA · UK · Updated Sep 4, 2026

Change to the definition of regulated activity with children from 1 September 2026

Urgency: High

Organizations must re-evaluate roles related to children's activities and prepare to request Enhanced DBS checks including access to the Children’s Barred List check starting from 1 September 2026.

Country ComplianceRegulatory Intelligence Lead
SOP Impact1 SOPs
ConfidenceHigh
Relevant for: Regulatory Intelligence Lead
verifiedRegulatory action: Regulators
Read impact briefarrow_forward
publicUK Health Security Agency · UK · Updated Sep 7, 2026

Low Flu Vaccination Rates Among Primary School Children

Urgency: High

Parents are reminded to complete and return flu vaccination consent forms promptly as vaccination sessions in schools are set to start this week, aiming for completion by late November.

Signal ManagementPV Quality Lead
SOP Impact1 SOPs
ConfidenceHigh
Relevant for: PV Quality Lead, Medical Safety Lead
verifiedRegulatory action: Regulators
Read impact briefarrow_forward
publicANSM (France) · France · Updated Sep 7, 2026Translated From French

Recall of Gore Viabahn Endoprosthesis with Bioactive Heparin Coating

Urgency: High

Health establishments receiving affected devices must be notified, and protocols established to ensure compliance with the recall.

Signal ManagementQPPV
SOP Impact1 SOPs
ConfidenceHigh
Relevant for: QPPV, Medical Safety Lead
verifiedRegulatory action: Regulators
Read impact briefarrow_forward